Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer
Clinical and Translational Science · 2025
DOI: 10.1111/cts.70323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, 2025. Verfasst von Rebecca Purvis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Health Personnel, Genetic Testing, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The clinical utility and implementation of polygenic risk scores (PRS) in the setting of personalized risk assessment for hereditary breast and ovarian cancer (HBOC) continues to be investigated. We aimed to explore and analyze genetic healthcare providers' perspectives toward national implementation in Australia, acknowledging the vitality of provider knowledge, priorities, and support. A two‐phase exploratory, cross‐sectional, mixed‐method study was conducted, consisting of semistructured interviews and a national online survey. Participants were recruited through professional networks. Interview schedule, survey design, and analyses were informed by the Consolidated Framework from Implementation Research (CFIR), the Theoretical Domains Framework (TDF) and the Expert Recommendations for Implementing Change (ERIC) compilation of facilitative strategies. Surveys were analyzed using descriptive and inferential statistics. Twenty‐seven participants were interviewed and forty completed the survey. Participants were supportive of clinical implementation of PRS, with implementation enablers in sector culture, compatibility with practice and professional role, and providers' knowledge and skills. Concerns were raised on insufficient resourcing, equity and timeliness of delivery, and the safety and effectiveness of ovarian cancer PRS. Training and educating stakeholders and achieving standardization, including establishing an accredited test, national guidelines, care and funding models, and results reports, were implementation priorities. Findings will support the design of a provider‐informed model or framework to plan and prioritize the next steps toward national implementation. Resourcing will be a key challenge. Current enablers in the sector, evidence‐based implementation strategies, and direction of efforts toward these priorities of education and standardization will enhance implementation readiness and efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- School of Population Health, Faculty of Medicine & Health, The University of New South Wales, Sydney, New South Wales, Australia.
- Clinical Translation and Engagement Platform, The Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
- School of Clinical Medicine & Health, the University of New South Wales St Vincent's Clinical Campus, Sydney, New South Wales, Australia.
- Department of Medicine, the Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Rebecca Purvis, Natalie Taylor, Mary-Anne Young, Paul James, Laura E Forrest
Zitieren
APA
Purvis, R., Taylor, N., Young, M. A., James, P., & Forrest, L. E. (2025). Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer. Clinical and Translational Science. https://doi.org/10.1111/cts.70323
Vancouver
Purvis R, Taylor N, Young MA, James P, Forrest LE. Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer. Clinical and Translational Science. 2025. doi:10.1111/cts.70323
BibTeX
@article{Purvis2025,
author = {Purvis, Rebecca and Taylor, Natalie and Young, Mary-Anne and James, Paul and Forrest, Laura E},
title = {Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer},
journal = {Clinical and Translational Science},
year = {2025},
doi = {10.1111/cts.70323}
}
EUVIMED